CN110787074A - Composition for fading fine lines - Google Patents
Composition for fading fine lines Download PDFInfo
- Publication number
- CN110787074A CN110787074A CN201911017454.9A CN201911017454A CN110787074A CN 110787074 A CN110787074 A CN 110787074A CN 201911017454 A CN201911017454 A CN 201911017454A CN 110787074 A CN110787074 A CN 110787074A
- Authority
- CN
- China
- Prior art keywords
- component
- percent
- butanediol
- water
- glycerol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a composition for fading fine wrinkles, which mainly contains multiple active ingredients such as hydrolytic yeast extract, wild soybean seed extract, euglena gracilis polysaccharide, royal jelly extract and the like, and is compounded for use. The composition for fading fine wrinkles can promote skin to be better absorbed, is beneficial to skin damage repair, nourishes skin, supplements skin moisture, consolidates repair effect, reduces the proportion of irritant substances, and makes the product safer and more reliable. The invention can be widely applied to skin care products such as eye cream, eye patches and the like.
Description
Technical Field
The invention belongs to the field of skin care products, and particularly relates to a composition for fading fine lines.
Background
The fine lines and wrinkles of the eyes are formed by that the skin of the eyes is affected by the external environment to form free radicals, the free radicals destroy collagen and active substances in normal cell membrane tissues and oxidize cells. 1. Among facial skins, skin around eyes is thinnest with a thickness of only 0.4 mm due to insufficient moisture. Because of this part of the skin, it has no sebaceous glands, sweat glands, and is very thin. Therefore, the skin around the eyes has a weak protective function, and in addition, moisture in the skin around the eyes is easily evaporated, and when the moisture retention capacity is poor, dryness becomes the most likely problem. 2. Excessive use of eyes, long-term computer facing and various bad habits such as frequent squinting or blinking can easily cause the aging of eye skin and fine lines. 3. Blood circulation is not good, and because the skin of the eye is thin, blood vessels in the opposite skin are thin and few, so that it is difficult to transport nutrients and oxygen into skin cells, and capillary circulation around the eye is easy to stagnate.
Skin care products or cosmetics in the market are mainly for the face, and products specially used for fading fine lines of eyes and nursing the skin of the eyes are few, the effect is still not ideal, and users still need a safe and efficient eye skin nursing product.
Disclosure of Invention
The invention aims to provide a composition with a fine line fading function
The technical scheme adopted by the invention is as follows: a fine grain reduction composition, said fine grain reduction composition consisting of A, B, C, D, E, F, G, H, I, J, K, L, M components; wherein:
the component A is prepared from water, dipropylene glycol, isohexadecane, caprylic/capric triglyceride, hydrogenated coconut oil glyceride, butanediol, propylene glycol, glycerol, stearyl alcohol, shea butter, mineral oil, polydimethylsiloxane, pulvis Talci, stearic acid, PEG-60 glyceryl isostearate, behenyl alcohol, glucosyl hesperidin, 1, 2-pentanediol, trehalose, and silica, panthenol, cholesteryl hydroxy-stearic acid ester, carnosine, tocopherol acetate, allantoin, phenoxyethanol, potassium cetyl phosphate, triethanolamine, acrylic acid or esters/C10-30 alkanol acrylate crosspolymer, caprylyl glycol, EDTA-disodium, sodium hyaluronate, resveratrol, rosa damascena flower extract, essence, a colorant CI75470, a colorant CI 15985, a colorant CI19140, and a colorant CI 17200;
the component B consists of arachidyl alcohol, behenyl alcohol and arachidyl alcohol glucoside;
the component C comprises a split yeast fermentation product filtrate, caprylyl hydroximic acid, propylene glycol, glyceryl caprylate and phenoxyethanol;
the component D consists of butanediol and a hydrolytic yeast extract;
the component E consists of hydroxyphenylpropionamide benzoic acid, ascorbyl palmitate, butanediol, 1, 2-pentanediol,
The component F comprises semen glycines extract and glycerol;
the G component consists of euglena gracilis polysaccharide and hydrolyzed collagen;
the H component comprises water, palmitoyl oligopeptide, palmitoyl tetrapeptide-7, butanediol, carbomer, glycerol and polysorbate-20;
the component I comprises water, hydrolyzed elastin, citric acid, tropolone, polysorbate-20, octyl glycol, ethylhexyl glycerin and 1, 2-hexanediol;
the J component consists of water, palmitoyl pentapeptide-4, glycerol, butanediol, carbomer and polysorbate-20;
the component K consists of water, ceramide 3, caprylic/capric triglyceride, cholesterol, hydrogenated lecithin, phytosphingosine, stearic acid, oleic acid and lactic acid;
the L component comprises apple fruit cell culture extract, glycerol, lecithin, xanthan gum and phenoxyethanol;
the M component comprises water, butanediol, and Lac Regis Apis extract.
The composition for fading fine lines comprises the following components in percentage by weight:
the component A comprises 50-72% of water, 3-65% of dipropylene glycol, 2-5% of isohexadecane, 2-6% of caprylic/capric triglyceride, 2-4% of cocoglycerides, 1-4% of butanediol, 1-3% of propylene glycol, 1-3% of glycerol, 1-4% of stearyl alcohol, 1-2% of shea butter, 1-3% of mineral oil, 1-3% of polydimethylsiloxane, 0.5-2% of talcum powder, 0.3-2% of stearic acid, 0.5-2% of PEG-60 glyceryl isostearate, 0.3-2% of behenyl alcohol, 0.5-2% of glucosyl hesperidin, 0.3-1% of 1, 2-pentanediol, 0.2-0.8% of trehalose, 0.2-1.2% of silica, 2-1.2% of glycerol, and a mixture of a solvent, wherein the components are mixed together to obtain a mixture, 0.2-1.5% panthenol, 0.1-0.5% cholesteryl hydroxy stearic acid ester, 0.1-1% carnosine, 0.1-1% tocopherol acetate, 0.02-0.5% allantoin, 0.3-0.6% phenoxyethanol, 0.1-0.5% potassium cetyl phosphate, 0.2-0.5% triethanolamine, 0.1-0.5% acrylic acid or ester/C10-30 alkanol acrylate crosspolymer, 0.1-0.4% caprylyl glycol, 0.05-0.2% of EDTA-disodium, 0.001-0.005% of sodium hyaluronate, 0.0001-0.02% of resveratrol, 0.0001-0.01% of rosa damascena flower extract, 0.1-0.2% of essence, 0.00001-0.00002% of colorant CI75470, 0.00003-0.00006% of colorant CI 15985, 0.00001-0.00003% of colorant CI19140 and 0.00001-0.00002% of colorant CI 17200;
the component B consists of arachidyl alcohol, behenyl alcohol and arachidyl glucoside, and accounts for 1-4% of the total;
the component C comprises 1-3% of a secondary fission yeast fermentation product filtrate, caprylyl hydroximic acid, propylene glycol, glyceryl caprylate and phenoxyethanol;
the component D comprises butanediol and hydrolytic yeast extract, accounting for 0.2-2% of the total;
the component E consists of hydroxyphenyl propionamide benzoic acid, ascorbyl palmitate, butanediol and 1, 2-pentanediol, and accounts for 0.1-0.5% of the total;
the component F comprises semen glycines extract and glycerol, and accounts for 0.05-0.5%;
the G component consists of euglena gracilis polysaccharide and hydrolyzed collagen, and accounts for 0.01-0.5% of the total;
the H component consists of water, palmitoyl oligopeptide, palmitoyl tetrapeptide-7, butanediol, carbomer, glycerol and polysorbate-20, and accounts for 0.001-0.5%;
the component I comprises water, hydrolyzed elastin, citric acid, tropolone, polysorbate-20, octyl glycol, ethylhexyl glycerol, and 1, 2-hexanediol, and accounts for 0.001-0.3%;
the J component consists of water, palmitoyl pentapeptide-4, glycerol, butanediol, carbomer and polysorbate-20, and accounts for 0.001-2%;
the component K consists of water, ceramide 3, caprylic/capric triglyceride, cholesterol, hydrogenated lecithin, phytosphingosine, stearic acid, oleic acid and lactic acid, and accounts for 0.001-0.5% of the total;
the L component comprises apple fruit cell culture extract, glycerol, lecithin, xanthan gum and phenoxyethanol, and accounts for 0.001-0.5% of the total;
the M component comprises water, butanediol, and Lac Regis Apis extract, and accounts for 0.001-0.2% of the total amount.
The sum of the components A to M is 100%.
In some embodiments, the fine line fading composition consists of the following weight percentages:
the component A comprises 54.435893% of water, 5% of dipropylene glycol, 4% of isohexadecane, 4% of caprylic/capric triglyceride, 3% of cocoglycerides, 2% of butanediol, 2% of propylene glycol, 2% of glycerol, 2% of stearyl alcohol, 2% of shea butter, 2% of mineral oil, 2% of polydimethylsiloxane, 1% of talcum powder, 1% of stearic acid, 1% of PEG-60 glyceryl isostearate, 1% of behenyl alcohol, 1% of glucosyl hesperidin, 0.5% of 1, 2-pentanediol, 0.5% of trehalose, 0.5% of silica, 0.5% of panthenol, 0.3% of cholesteryl hydroxy stearic acid ester, 0.3% of carnosine, 0.3% of tocopheryl acetate, 0.3% of allantoin, 0.3% of phenoxyethanol, 0.2% of cetyl alcohol phosphate, 0.2% of triethanolamine acrylate, 0.2% of acrylic acid ester 10% of cross-linked polymer of C30-32C-C.3% of acrylic acid, 0.2% of caprylyl glycol, 0.1% of EDTA-disodium, 0.003% of sodium hyaluronate, 0.0005% of resveratrol, 0.0005% of rosa damascena flower extract, 0.1% of essence, 0.00002% of colorant CI75470, 0.00003% of colorant CI 15985, 0.00001% of colorant CI19140 and 0.00001% of colorant CI 17200;
the component B consists of 0.5 percent of arachidyl alcohol, 0.5 percent of behenyl alcohol and 0.5 percent of arachidyl alcohol glucoside;
the component C comprises 0.01% of a fermentation product filtrate of the yeast schizosaccharomyces, 0.1% of caprylyl hydroximic acid, 1% of propylene glycol, 0.1% of glyceryl caprylate and 0.1% of phenoxyethanol;
the component D comprises 0.5% of butanediol and 0.1% of hydrolytic yeast extract;
the component E consists of 0.05 percent of hydroxyphenylpropionamide benzoic acid, 0.05 percent of ascorbyl palmitate, 0.1 percent of butanediol and 0.1 percent of 1, 2-pentanediol;
the component F comprises 0.05% of extract of semen glycines and 0.2% of glycerol;
the G component consists of 0.05 percent of euglena gracilis polysaccharide and 0.05 percent of hydrolyzed collagen;
the H component comprises 0.2% of water, 0.005% of palmitoyl oligopeptide, 0.005% of palmitoyl tetrapeptide-7, 0.005% of butanediol, 0.1% of carbomer, 0.1% of glycerol and 0.005% of polysorbate-20;
component I consists of 0.05% of water, 0.0005% of hydrolyzed elastin, 0.1% of citric acid, 0.0005% of tropolone, 0.005% of polysorbate-20, 0.02% of caprylyl glycol, 0.02% of ethylhexyl glycerin, 0.05% of 1, 2-hexanediol;
the J component consists of 0.5% of water, 0.005% of palmitoyl pentapeptide-4, 0.5% of glycerin, 0.005% of butanediol, 0.05% of carbomer and 0.05% of polysorbate-20;
the K component consists of 0.05 percent of water, 0.005 percent of ceramide 3, 0.05 percent of caprylic/capric triglyceride, 0.005 percent of cholesterol, 0.005 percent of hydrogenated lecithin, 0.005 percent of phytosphingosine, 0.01 percent of stearic acid, 0.01 percent of oleic acid and 0.01 percent of lactic acid;
the L component comprises 0.05% of apple fruit cell culture extract, 0.01% of glycerol, 0.01% of lecithin, 0.01% of xanthan gum and 0.01% of phenoxyethanol;
the M component comprises 0.1% of water, 0.05% of butanediol, and 0.01% of royal jelly extract.
The preparation method of the composition for fading the fine lines comprises the following steps:
1) weighing the component A into a water phase pot, stirring and heating;
2) weighing the components B to M, and respectively stirring and mixing for later use;
3) adding the component A, stirring and heating to 80-85 ℃, placing in an emulsifying pot, vacuumizing to 500pa, stirring at 20rpm, emulsifying at 3200rpm, after vacuum emulsification for 5 minutes, beginning to stir, cooling to 50 ℃, adding B, C, D, E items, stirring and cooling to 40 ℃ after vacuum stirring for 3 minutes, adding the component F, G, H, I, J, K, L, M, and vacuum emulsification for 2 minutes, thus discharging.
The invention has the beneficial effects that: the invention combines and uses a plurality of active ingredients such as hydrolytic yeast extract, wild soybean seed extract, euglena gracilis polysaccharide, royal jelly extract, and the like, thereby not only promoting better absorption of skin and being beneficial to the damage repair of skin, but also nourishing skin, supplementing skin moisture, consolidating the repair effect, reducing the proportion of irritant substances and ensuring that the product is safer and more reliable. The invention can be widely applied to skin care products such as eye cream, eye patches and the like.
Detailed Description
The invention will be further illustrated with reference to specific examples.
The composition for reducing fine lines in the examples consisted of A, B, C, D, E, F, G, H, I, J, K, L, M components. The proportioning percentage is as follows:
the component A comprises 50-72% of water, 3-65% of dipropylene glycol, 2-5% of isohexadecane, 2-6% of caprylic/capric triglyceride, 2-4% of cocoglycerides, 1-4% of butanediol, 1-3% of propylene glycol, 1-3% of glycerol, 1-4% of stearyl alcohol, 1-2% of shea butter, 1-3% of mineral oil, 1-3% of polydimethylsiloxane, 0.5-2% of talcum powder, 0.3-2% of stearic acid, 0.5-2% of PEG-60 glyceryl isostearate, 0.3-2% of behenyl alcohol, 0.5-2% of glucosyl hesperidin, 0.3-1% of 1, 2-pentanediol, 0.2-0.8% of trehalose, 0.2-1.2% of silica, 2-1.2% of glycerol, and a mixture of a solvent, wherein the components are mixed together to obtain a mixture, 0.2-1.5% panthenol, 0.1-0.5% cholesteryl hydroxy stearic acid ester, 0.1-1% carnosine, 0.1-1% tocopherol acetate, 0.02-0.5% allantoin, 0.3-0.6% phenoxyethanol, 0.1-0.5% potassium cetyl phosphate, 0.2-0.5% triethanolamine, 0.1-0.5% acrylic acid or ester/C10-30 alkanol acrylate crosspolymer, 0.1-0.4% caprylyl glycol, 0.05-0.2% of EDTA-disodium, 0.001-0.005% of sodium hyaluronate, 0.0001-0.02% of resveratrol, 0.0001-0.01% of rosa damascena flower extract, 0.1-0.2% of essence, 0.00001-0.00002% of colorant CI75470, 0.00003-0.00006% of colorant CI 15985, 0.00001-0.00003% of colorant CI19140 and 0.00001-0.00002% of colorant CI 17200;
the component B consists of arachidyl alcohol, behenyl alcohol and arachidyl glucoside, and accounts for 1-4% of the total;
the component C comprises 1-3% of a secondary fission yeast fermentation product filtrate, caprylyl hydroximic acid, propylene glycol, glyceryl caprylate and phenoxyethanol;
the component D comprises butanediol and hydrolytic yeast extract, accounting for 0.2-2% of the total;
the component E consists of hydroxyphenyl propionamide benzoic acid, ascorbyl palmitate, butanediol and 1, 2-pentanediol, and accounts for 0.1-0.5% of the total;
the component F comprises semen glycines extract and glycerol, and accounts for 0.05-0.5%;
the G component consists of euglena gracilis polysaccharide and hydrolyzed collagen, and accounts for 0.01-0.5% of the total;
the H component consists of water, palmitoyl oligopeptide, palmitoyl tetrapeptide-7, butanediol, carbomer, glycerol and polysorbate-20, and accounts for 0.001-0.5%;
the component I comprises water, hydrolyzed elastin, citric acid, tropolone, polysorbate-20, octyl glycol, ethylhexyl glycerol, and 1, 2-hexanediol, and accounts for 0.001-0.3%;
the J component consists of water, palmitoyl pentapeptide-4, glycerol, butanediol, carbomer and polysorbate-20, and accounts for 0.001-2%;
the component K consists of water, ceramide 3, caprylic/capric triglyceride, cholesterol, hydrogenated lecithin, phytosphingosine, stearic acid, oleic acid and lactic acid, and accounts for 0.001-0.5% of the total;
the L component comprises apple fruit cell culture extract, glycerol, lecithin, xanthan gum and phenoxyethanol, and accounts for 0.001-0.5% of the total;
the M component comprises water, butanediol, and Lac Regis Apis extract, and accounts for 0.001-0.2% of the total amount.
The preparation method of the composition for fading the fine lines comprises the following steps:
1) weighing the component A into a water phase pot, stirring and heating;
2) weighing the components B to M, and respectively stirring and mixing for later use;
3) adding the component A, stirring and heating to 80-85 ℃, placing in an emulsifying pot, vacuumizing to 500pa, stirring at 20rpm, emulsifying at 3200rpm, after vacuum emulsification for 5 minutes, beginning to stir, cooling to 50 ℃, adding B, C, D, E items, stirring and cooling to 40 ℃ after vacuum stirring for 3 minutes, adding the component F, G, H, I, J, K, L, M, and vacuum emulsification for 2 minutes, thus discharging.
Example 1:
the component A comprises 54.435893% of water, 5% of dipropylene glycol, 4% of isohexadecane, 4% of caprylic/capric triglyceride, 3% of cocoglycerides, 2% of butanediol, 2% of propylene glycol, 2% of glycerol, 2% of stearyl alcohol, 2% of shea butter, 2% of mineral oil, 2% of polydimethylsiloxane, 1% of talcum powder, 1% of stearic acid, 1% of PEG-60 glyceryl isostearate, 1% of behenyl alcohol, 1% of glucosyl hesperidin, 0.5% of 1, 2-pentanediol, 0.5% of trehalose, 0.5% of silica, 0.5% of panthenol, 0.3% of cholesteryl hydroxy stearic acid ester, 0.3% of carnosine, 0.3% of tocopheryl acetate, 0.3% of allantoin, 0.3% of phenoxyethanol, 0.2% of cetyl alcohol phosphate, 0.2% of triethanolamine acrylate, 0.2% of acrylic acid ester 10% of cross-linked polymer of C30-32C-C.3% of acrylic acid, 0.2% of caprylyl glycol, 0.1% of EDTA-disodium, 0.003% of sodium hyaluronate, 0.0005% of resveratrol, 0.0005% of rosa damascena flower extract, 0.1% of essence, 0.00002% of colorant CI75470, 0.00003% of colorant CI 15985, 0.00001% of colorant CI19140 and 0.00001% of colorant CI 17200;
the component B consists of 0.5 percent of arachidyl alcohol, 0.5 percent of behenyl alcohol and 0.5 percent of arachidyl alcohol glucoside;
the component C comprises 0.01% of a fermentation product filtrate of the yeast schizosaccharomyces, 0.1% of caprylyl hydroximic acid, 1% of propylene glycol, 0.1% of glyceryl caprylate and 0.1% of phenoxyethanol;
the component D comprises 0.5% of butanediol and 0.1% of hydrolytic yeast extract;
the component E consists of 0.05 percent of hydroxyphenylpropionamide benzoic acid, 0.05 percent of ascorbyl palmitate, 0.1 percent of butanediol and 0.1 percent of 1, 2-pentanediol;
the component F comprises 0.05% of extract of semen glycines and 0.2% of glycerol;
the G component consists of 0.05 percent of euglena gracilis polysaccharide and 0.05 percent of hydrolyzed collagen;
the H component comprises 0.2% of water, 0.005% of palmitoyl oligopeptide, 0.005% of palmitoyl tetrapeptide-7, 0.005% of butanediol, 0.1% of carbomer, 0.1% of glycerol and 0.005% of polysorbate-20;
component I consists of 0.05% of water, 0.0005% of hydrolyzed elastin, 0.1% of citric acid, 0.0005% of tropolone, 0.005% of polysorbate-20, 0.02% of caprylyl glycol, 0.02% of ethylhexyl glycerin, 0.05% of 1, 2-hexanediol;
the J component consists of 0.5% of water, 0.005% of palmitoyl pentapeptide-4, 0.5% of glycerin, 0.005% of butanediol, 0.05% of carbomer and 0.05% of polysorbate-20;
the K component consists of 0.05 percent of water, 0.005 percent of ceramide 3, 0.05 percent of caprylic/capric triglyceride, 0.005 percent of cholesterol, 0.005 percent of hydrogenated lecithin, 0.005 percent of phytosphingosine, 0.01 percent of stearic acid, 0.01 percent of oleic acid and 0.01 percent of lactic acid;
the L component comprises 0.05% of apple fruit cell culture extract, 0.01% of glycerol, 0.01% of lecithin, 0.01% of xanthan gum and 0.01% of phenoxyethanol;
the M component comprises 0.1% of water, 0.05% of butanediol, and 0.01% of royal jelly extract.
Example 2:
the component A comprises 54.315893% of water, 5% of dipropylene glycol, 4% of isohexadecane, 4% of caprylic/capric triglyceride, 3% of cocoglycerides, 2% of butanediol, 2% of propylene glycol, 2% of glycerol, 2% of stearyl alcohol, 2% of shea butter, 2% of mineral oil, 2% of polydimethylsiloxane, 1% of talcum powder, 1% of stearic acid, 1% of PEG-60 glyceryl isostearate, 1% of behenyl alcohol, 1% of glucosyl hesperidin, 0.5% of 1, 2-pentanediol, 0.5% of trehalose, 0.5% of silica, 0.5% of panthenol, 0.3% of cholesteryl hydroxy stearic acid ester, 0.3% of carnosine, 0.3% of tocopheryl acetate, 0.3% of allantoin, 0.3% of phenoxyethanol, 0.2% of cetyl alcohol phosphate, 0.2% of triethanolamine acrylate, 0.2% of acrylic acid ester 10% of cross-linked polymer of C30-32C-C.3% of acrylic acid, 0.2% of caprylyl glycol, 0.1% of EDTA-disodium, 0.003% of sodium hyaluronate, 0.0005% of resveratrol, 0.0005% of rosa damascena flower extract, 0.1% of essence, 0.00002% of colorant CI75470, 0.00003% of colorant CI 15985, 0.00001% of colorant CI19140 and 0.00001% of colorant CI 17200;
the component B consists of 0.5 percent of arachidyl alcohol, 0.5 percent of behenyl alcohol and 0.5 percent of arachidyl alcohol glucoside;
the component C comprises 0.01% of a fermentation product filtrate of the yeast schizosaccharomyces, 0.1% of caprylyl hydroximic acid, 1% of propylene glycol, 0.1% of glyceryl caprylate and 0.1% of phenoxyethanol;
the component D comprises 0.5% of butanediol and 0.1% of hydrolytic yeast extract;
the component E consists of 0.05 percent of hydroxyphenylpropionamide benzoic acid, 0.05 percent of ascorbyl palmitate, 0.1 percent of butanediol and 0.1 percent of 1, 2-pentanediol;
the component F comprises 0.05% of extract of semen glycines and 0.2% of glycerol;
the G component consists of 0.1 percent of euglena gracilis polysaccharide and 0.1 percent of hydrolyzed collagen;
the H component comprises 0.2% of water, 0.005% of palmitoyl oligopeptide, 0.005% of palmitoyl tetrapeptide-7, 0.005% of butanediol, 0.1% of carbomer, 0.1% of glycerol and 0.005% of polysorbate-20;
component I consists of 0.05% of water, 0.0005% of hydrolyzed elastin, 0.1% of citric acid, 0.0005% of tropolone, 0.005% of polysorbate-20, 0.02% of caprylyl glycol, 0.02% of ethylhexyl glycerin, 0.05% of 1, 2-hexanediol;
the J component consists of 0.5% of water, 0.005% of palmitoyl pentapeptide-4, 0.5% of glycerin, 0.005% of butanediol, 0.05% of carbomer and 0.05% of polysorbate-20;
the K component consists of 0.05 percent of water, 0.01 percent of ceramide 3, 0.05 percent of caprylic/capric triglyceride, 0.01 percent of cholesterol, 0.01 percent of hydrogenated lecithin, 0.01 percent of phytosphingosine, 0.01 percent of stearic acid, 0.01 percent of oleic acid and 0.01 percent of lactic acid;
the L component comprises 0.05% of apple fruit cell culture extract, 0.1% of glycerol, 0.1% of lecithin, 0.1% of xanthan gum and 0.1% of phenoxyethanol;
the M component comprises 0.1% of water, 0.05% of butanediol, and 0.01% of royal jelly extract.
Example 3:
the antioxidant activity (AOA) was determined for inventive example 1 and comparative example (patent 2004800222529 example 1), AOA representing the coulomb consumption of 100g of the analyzed material, as shown in table 1:
TABLE 1
Inventive example 1 | Inventive example 2 | Comparative example | |
AOA,kCb/100g | 269.6 | 265.9 | 240 |
As can be seen from Table 1, the AOA value of the cosmetic prepared by the present invention is significantly higher than that of the comparative example, indicating that the cosmetic of the present invention has strong oxidation resistance and can effectively scavenge free radicals.
Skin complexion L values were measured using a Colorimeter CL400, a skin color tester produced by Courage Khazaka (CK) of germany, to evaluate the effect on skin penetration by measuring the change in the L value of the skin before and after use of the product, and three groups of subjects having the same mean value of the initial L values were tested, 10 per group, for a period of 4 weeks, and the results were averaged as shown in table 2:
TABLE 2
Inventive example 1 | Inventive example 2 | Comparative example | |
0 week | 45.0 | 45.0 | 45.0 |
4 weeks | 59.5 | 58.1 | 50.3 |
As can be seen from table 2 above, the L value of the present invention increases at a rate significantly higher than the comparative example after four weeks of use of the product, indicating that the whitening effect of the present invention is significant and the skin brightness is high after use.
Skin hydration was measured to have the same starting mean for three groups of 10 subjects over a four week period, and the results averaged, as in table 3:
TABLE 3
Inventive example 1 | Inventive example 2 | Comparative example | |
0 week | 23.0 | 23.0 | 23.0 |
4 weeks | 37.4 | 36.9 | 33.3 |
As can be seen from table 3 above, the product of the present invention increases the skin hydration rate of the subject rapidly, is significantly superior to the comparative example, and shows that the moisturizing effect of the present invention is good, and can restore dry skin to a state of sufficient moisture.
The above detailed description is specific to one possible embodiment of the present invention, and the embodiment is not intended to limit the scope of the present invention, and all equivalent implementations or modifications without departing from the scope of the present invention should be included in the technical scope of the present invention.
Claims (7)
1. A composition for reducing fine lines, comprising: the fine line fading composition consists of A, B, C, D, E, F, G, H, I, J, K, L, M components; wherein:
component A comprises water, dipropylene glycol, isohexadecane, caprylic/capric triglyceride, hydrogenated cocoglycerides, butylene glycol, propylene glycol, glycerol, stearyl alcohol, shea butter, mineral oil, polydimethylsiloxane, talc, stearic acid, PEG-60 glyceryl isostearate, behenyl alcohol, glucosyl hesperidin, 1, 2-pentanediol, trehalose, silica, panthenol, cholesteryl hydroxy-stearic acid ester, carnosine, tocopheryl acetate, allantoin, phenoxyethanol, potassium cetyl phosphate, triethanolamine, acrylic acid or esters/C10-30 alkanol acrylate crosspolymer, caprylyl glycol, EDTA-disodium, sodium hyaluronate, resveratrol, Rosa damascena extract, essence, colorant CI75470, colorant CI 15985, colorant 19140, and colorant 17200;
the component B consists of arachidyl alcohol, behenyl alcohol and arachidyl alcohol glucoside;
the component C comprises a split yeast fermentation product filtrate, caprylyl hydroximic acid, propylene glycol, glyceryl caprylate and phenoxyethanol;
the component D consists of butanediol and a hydrolytic yeast extract;
the component E consists of hydroxyphenylpropionamide benzoic acid, ascorbyl palmitate, butanediol, 1, 2-pentanediol,
The component F comprises semen glycines extract and glycerol;
the G component consists of euglena gracilis polysaccharide and hydrolyzed collagen;
the H component comprises water, palmitoyl oligopeptide, palmitoyl tetrapeptide-7, butanediol, carbomer, glycerol and polysorbate-20;
the component I comprises water, hydrolyzed elastin, citric acid, tropolone, polysorbate-20, octyl glycol, ethylhexyl glycerin and 1, 2-hexanediol;
the J component consists of water, palmitoyl pentapeptide-4, glycerol, butanediol, carbomer and polysorbate-20;
the component K consists of water, ceramide 3, caprylic/capric triglyceride, cholesterol, hydrogenated lecithin, phytosphingosine, stearic acid, oleic acid and lactic acid;
the L component comprises apple fruit cell culture extract, glycerol, lecithin, xanthan gum and phenoxyethanol;
the M component comprises water, butanediol, and Lac Regis Apis extract.
2. The composition for attenuating fine lines according to claim 1, characterized in that: the composition for fading fine lines comprises the following components in percentage by weight:
the component A comprises 50-72% of water, 3-65% of dipropylene glycol, 2-5% of isohexadecane, 2-6% of caprylic/capric triglyceride, 2-4% of cocoglycerides, 1-4% of butanediol, 1-3% of propylene glycol, 1-3% of glycerol, 1-4% of stearyl alcohol, 1-2% of shea butter, 1-3% of mineral oil, 1-3% of polydimethylsiloxane, 0.5-2% of talcum powder, 0.3-2% of stearic acid, 0.5-2% of PEG-60 glyceryl isostearate, 0.3-2% of behenyl alcohol, 0.5-2% of glucosyl hesperidin, 0.3-1% of 1, 2-pentanediol, 0.2-0.8% of trehalose, 0.2-1.2% of silica, 2-1.2% of glycerol, and a mixture of a solvent, wherein the components are mixed together to obtain a mixture, 0.2-1.5% panthenol, 0.1-0.5% cholesteryl hydroxy stearic acid ester, 0.1-1% carnosine, 0.1-1% tocopherol acetate, 0.02-0.5% allantoin, 0.3-0.6% phenoxyethanol, 0.1-0.5% potassium cetyl phosphate, 0.2-0.5% triethanolamine, 0.1-0.5% acrylic acid or ester/C10-30 alkanol acrylate crosspolymer, 0.1-0.4% caprylyl glycol, 0.05-0.2% of EDTA-disodium, 0.001-0.005% of sodium hyaluronate, 0.0001-0.02% of resveratrol, 0.0001-0.01% of rosa damascena flower extract, 0.1-0.2% of essence, 0.00001-0.00002% of colorant CI75470, 0.00003-0.00006% of colorant CI 15985, 0.00001-0.00003% of colorant CI19140 and 0.00001-0.00002% of colorant CI 17200;
the component B consists of arachidyl alcohol, behenyl alcohol and arachidyl glucoside, and accounts for 1-4% of the total;
the component C comprises 1-3% of a secondary fission yeast fermentation product filtrate, caprylyl hydroximic acid, propylene glycol, glyceryl caprylate and phenoxyethanol;
the component D comprises butanediol and hydrolytic yeast extract, accounting for 0.2-2% of the total;
the component E consists of hydroxyphenyl propionamide benzoic acid, ascorbyl palmitate, butanediol and 1, 2-pentanediol, and accounts for 0.1-0.5% of the total;
the component F comprises semen glycines extract and glycerol, and accounts for 0.05-0.5%;
the G component consists of euglena gracilis polysaccharide and hydrolyzed collagen, and accounts for 0.01-0.5% of the total;
the H component consists of water, palmitoyl oligopeptide, palmitoyl tetrapeptide-7, butanediol, carbomer, glycerol and polysorbate-20, and accounts for 0.001-0.5%;
the component I comprises water, hydrolyzed elastin, citric acid, tropolone, polysorbate-20, octyl glycol, ethylhexyl glycerol, and 1, 2-hexanediol, and accounts for 0.001-0.3%;
the J component consists of water, palmitoyl pentapeptide-4, glycerol, butanediol, carbomer and polysorbate-20, and accounts for 0.001-2%;
the component K consists of water, ceramide 3, caprylic/capric triglyceride, cholesterol, hydrogenated lecithin, phytosphingosine, stearic acid, oleic acid and lactic acid, and accounts for 0.001-0.5% of the total;
the L component comprises apple fruit cell culture extract, glycerol, lecithin, xanthan gum and phenoxyethanol, and accounts for 0.001-0.5% of the total;
the M component comprises water, butanediol, and Lac Regis Apis extract, and accounts for 0.001-0.2% of the total amount.
The sum of the components A to M is 100%.
3. The composition for lightening fine lines according to claims 1 and 2, wherein: the preferable components in the composition for fading fine lines are as follows in percentage by weight:
the component A comprises 54.435893% of water, 5% of dipropylene glycol, 4% of isohexadecane, 4% of caprylic/capric triglyceride, 3% of cocoglycerides, 2% of butanediol, 2% of propylene glycol, 2% of glycerol, 2% of stearyl alcohol, 2% of shea butter, 2% of mineral oil, 2% of polydimethylsiloxane, 1% of talcum powder, 1% of stearic acid, 1% of PEG-60 glyceryl isostearate, 1% of behenyl alcohol, 1% of glucosyl hesperidin, 0.5% of 1, 2-pentanediol, 0.5% of trehalose, 0.5% of silica, 0.5% of panthenol, 0.3% of cholesteryl hydroxy stearic acid ester, 0.3% of carnosine, 0.3% of tocopheryl acetate, 0.3% of allantoin, 0.3% of phenoxyethanol, 0.2% of cetyl alcohol phosphate, 0.2% of triethanolamine acrylate, 0.2% of acrylic acid ester 10% of cross-linked polymer of C30-32C-C.3% of acrylic acid, 0.2% of caprylyl glycol, 0.1% of EDTA-disodium, 0.003% of sodium hyaluronate, 0.0005% of resveratrol, 0.0005% of rosa damascena flower extract, 0.1% of essence, 0.00002% of colorant CI75470, 0.00003% of colorant CI 15985, 0.00001% of colorant CI19140 and 0.00001% of colorant CI 17200;
the component B consists of 0.5 percent of arachidyl alcohol, 0.5 percent of behenyl alcohol and 0.5 percent of arachidyl alcohol glucoside;
the component C comprises 0.01% of a fermentation product filtrate of the yeast schizosaccharomyces, 0.1% of caprylyl hydroximic acid, 1% of propylene glycol, 0.1% of glyceryl caprylate and 0.1% of phenoxyethanol;
the component D comprises 0.5% of butanediol and 0.1% of hydrolytic yeast extract;
the component E consists of 0.05 percent of hydroxyphenylpropionamide benzoic acid, 0.05 percent of ascorbyl palmitate, 0.1 percent of butanediol and 0.1 percent of 1, 2-pentanediol;
the component F comprises 0.05% of extract of semen glycines and 0.2% of glycerol;
the G component consists of 0.05 percent of euglena gracilis polysaccharide and 0.05 percent of hydrolyzed collagen;
the H component comprises 0.2% of water, 0.005% of palmitoyl oligopeptide, 0.005% of palmitoyl tetrapeptide-7, 0.005% of butanediol, 0.1% of carbomer, 0.1% of glycerol and 0.005% of polysorbate-20;
component I consists of 0.05% of water, 0.0005% of hydrolyzed elastin, 0.1% of citric acid, 0.0005% of tropolone, 0.005% of polysorbate-20, 0.02% of caprylyl glycol, 0.02% of ethylhexyl glycerin, 0.05% of 1, 2-hexanediol;
the J component consists of 0.5% of water, 0.005% of palmitoyl pentapeptide-4, 0.5% of glycerin, 0.005% of butanediol, 0.05% of carbomer and 0.05% of polysorbate-20;
the K component consists of 0.05 percent of water, 0.005 percent of ceramide 3, 0.05 percent of caprylic/capric triglyceride, 0.005 percent of cholesterol, 0.005 percent of hydrogenated lecithin, 0.005 percent of phytosphingosine, 0.01 percent of stearic acid, 0.01 percent of oleic acid and 0.01 percent of lactic acid;
the L component comprises 0.05% of apple fruit cell culture extract, 0.01% of glycerol, 0.01% of lecithin, 0.01% of xanthan gum and 0.01% of phenoxyethanol;
the M component comprises 0.1% of water, 0.05% of butanediol, and 0.01% of royal jelly extract.
4. A process for the preparation of a composition for lightening fine lines as claimed in any one of claims 1 to 3, characterized in that: the preparation method comprises the following steps:
1) weighing the component A into a water phase pot, stirring and heating;
2) weighing the components B to M, and respectively stirring and mixing for later use;
3) adding the component A, putting the mixture into an emulsifying pot, vacuumizing, stirring and emulsifying; after vacuum emulsification, stirring and cooling are started, and B, C, D, E items are added; stirring and cooling after vacuum stirring; adding F, G, H, I, J, K, L, M components, vacuum emulsifying, and discharging.
5. The method of claim 4, wherein: adding the component A, stirring and heating to 80-85 ℃, placing in an emulsifying pot, vacuumizing to 500pa, stirring at 20rpm, emulsifying at 3200rpm, after vacuum emulsification for 5 minutes, beginning to stir, cooling to 50 ℃, adding B, C, D, E items, after vacuum stirring for 3 minutes, stirring, cooling to 40 ℃, adding the component F, G, H, I, J, K, L, M, and performing vacuum emulsification for 2 minutes, thus obtaining the material.
6. A skin care product characterized by: the composition for fading fine lines as claimed in any one of claims 1 to 3 is added to the skin care product.
7. A skin care product according to claim 6, characterized in that: the skin care product is selected from any one of eye cream and eye patch.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911017454.9A CN110787074A (en) | 2019-10-24 | 2019-10-24 | Composition for fading fine lines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911017454.9A CN110787074A (en) | 2019-10-24 | 2019-10-24 | Composition for fading fine lines |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110787074A true CN110787074A (en) | 2020-02-14 |
Family
ID=69441282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911017454.9A Pending CN110787074A (en) | 2019-10-24 | 2019-10-24 | Composition for fading fine lines |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110787074A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111214418A (en) * | 2020-03-13 | 2020-06-02 | 佛山市奥姿美生物科技有限公司 | Efficient barrier repair composition and application thereof |
CN113304065A (en) * | 2021-05-08 | 2021-08-27 | 广州宝思利生物科技有限公司 | Scalp care composition and application thereof |
EP4059488A1 (en) * | 2021-03-19 | 2022-09-21 | Johnson & Johnson Consumer Inc. | Concentrated composition and uses of same |
-
2019
- 2019-10-24 CN CN201911017454.9A patent/CN110787074A/en active Pending
Non-Patent Citations (1)
Title |
---|
安婕妤化妆品科技股份有限公司: "安婕妤臻美无龄眼霜(升级版)", 《国产非特殊用途化妆品备案服务平台》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111214418A (en) * | 2020-03-13 | 2020-06-02 | 佛山市奥姿美生物科技有限公司 | Efficient barrier repair composition and application thereof |
EP4059488A1 (en) * | 2021-03-19 | 2022-09-21 | Johnson & Johnson Consumer Inc. | Concentrated composition and uses of same |
WO2022195404A1 (en) * | 2021-03-19 | 2022-09-22 | Johnson & Johnson Consumer Inc. | Concentrated composition and uses of same |
CN113304065A (en) * | 2021-05-08 | 2021-08-27 | 广州宝思利生物科技有限公司 | Scalp care composition and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110731923B (en) | Enhanced moisturizing cosmetic compositions | |
CN105769666B (en) | A kind of composition and the skin care item containing said composition | |
JP2021020887A (en) | Enhanced anti-aging cosmetic composition | |
CN110731928A (en) | Anti-aging cosmetic composition | |
CN110787074A (en) | Composition for fading fine lines | |
CN110742852A (en) | Composition for multi-effect repair of sensitive skin and preparation method and application thereof | |
CN109381356A (en) | A kind of sleep late frost and preparation method thereof | |
CN115607499B (en) | Ginseng ganoderma lucidum polypeptide composition for resisting wrinkle and compacting and application thereof | |
CN110721120A (en) | Multifunctional skin care cream and preparation method thereof | |
CN114848520B (en) | Whitening and repairing composition and application thereof | |
CN114848542A (en) | Black truffle cosmetic composition, black truffle face cream and preparation method thereof | |
CN111557892A (en) | Cosmetic composition containing prebiotics | |
CN115252516A (en) | Water-feeling blush and preparation method thereof | |
CN110812262A (en) | Anti-wrinkle firming composition | |
CN109260086B (en) | Anti-wrinkle essence, preparation method and application thereof | |
CN116637042A (en) | Wrinkle-removing anti-aging skin care product and preparation method and application thereof | |
CN114288201B (en) | Composition for removing pouch and fading black eye, and preparation method and application thereof | |
CN110302117A (en) | Compact shining face essence cream of one kind and preparation method thereof | |
CN110585080A (en) | Skin care product containing cracked yeast cell wall-broken extract | |
CN111773151B (en) | Whitening and freckle-removing antioxidant emulsion and preparation method thereof | |
CN113197809B (en) | Preparation method of skin care product containing phaeodactylum and tara fermentation compound | |
CN114159333A (en) | Muscle foundation liquid and preparation method thereof | |
CN112933010A (en) | Whitening and repairing cream and preparation method thereof | |
CN112773732A (en) | Moisturizing repair cream containing fibroin and preparation method thereof | |
CN111467269A (en) | Health product containing Tuber summer fungus extract and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200214 |